Bladder Cancer
HIVEC as an alternative option in non-muscle-invasive bladder cancer: Experiences from a high-volume center.
April 25, 2024
Preclinical models for bladder cancer therapy research.
April 24, 2024
Treatment patterns and clinical outcomes in metastatic urothelial carcinoma: a German retrospective real-world analysis.
April 24, 2024
Predicting non-muscle invasive bladder cancer outcomes using artificial intelligence: a systematic review using APPRAISE-AI.
April 22, 2024
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.
April 22, 2024
Spatial comparison of molecular features associated with resistance to pembrolizumab in BCG unresponsive bladder cancer.
April 19, 2024
Adjuvant intravesical therapy in intermediate-risk non-muscle-invasive bladder cancer.
April 18, 2024
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients.
April 17, 2024
Prophylactic Use of Biologic Mesh in Ileal Conduit (PUBMIC): A Randomized Clinical Trial.
April 17, 2024
Long-Term Outcomes in Patients with Localized Plasmacytoid Bladder Cancer - Expert Commentary
April 16, 2024